PRKN and metabolic disease: Emerging evidence suggests that the activity and functional regulation of E3 ubiquitin ligases are controlled by accessory proteins or adaptor proteins6, highlighting the importance of E3 ubiquitin ligases and their adaptors in the development of metabolic diseases.